Name File Type Size Last Modified
  2020.01.27 05/25/2021 11:45:AM
CHANGELOG.txt text/plain 687 bytes 05/24/2021 03:22:PM
File Manifest.txt text/plain 47.6 KB 05/25/2021 08:09:AM
README.pdf application/pdf 104.9 KB 05/24/2021 03:22:PM

Project Citation: 

Ody, Christopher, Starc, Amanda, and Dranove, David. Data and Code for: A Dose of Managed Care? Nashville, TN: American Economic Association [publisher], 2021. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], 2021-05-25. https://doi.org/10.3886/E115927V1

Project Description

Summary:  View help for Summary
We study the effect of privatizing Medicaid drug benefits on drug prices and utilization. Drug spending would decrease by 21.3 percent if private insurers administered all drug benefits. One-third of the decrease is driven by private insurers’ ability to negotiate prices with pharmacies. The remaining two-thirds is driven by the greater use of lower cost drugs, such as generics, and is only realized in states that give private insurers the flexibility to design drug benefits. Privatization does not reduce prescriptions per enrollee and spending cuts are smaller for drugs that lower medical spending.

Scope of Project

JEL Classification:  View help for JEL Classification
      I11 Analysis of Health Care Markets
      I13 Health Insurance, Public and Private
      L10 Market Structure, Firm Strategy, and Market Performance: General


Related Publications

Published Versions

Export Metadata

Report a Problem

Found a serious problem with the data, such as disclosure risk or copyrighted content? Let us know.

This material is distributed exactly as it arrived from the data depositor. ICPSR has not checked or processed this material. Users should consult the investigator(s) if further information is desired.